Mission – A Biosensor Revolution
Our mission is to develop and commercialize an open-architecture, multi-analyte biosensor
platform setting new industry standards for fast, accurate and low-cost bioassay results
throughout the life sciences industry, enabling the era of precision medicine.
Our Opportunity
STI is developing disruptive new “gold-standards” in research instrumentation and medical
diagnostic equipment by integrating its proprietary micro-cavity surface plasmon resonance
(MSPR) biosensor technology in high performance substrate and cost effective reader.
The MSPR technology is enabling faster results with higher sensitivity and multiplexing
capabilities at a fraction of the price of current SPR technologies. As a result, MSPR
technology will disrupt the market for the study of molecular interaction and ultimately
transform the way diseases are diagnosed and monitored by enabling real time continuous
monitoring.
Our mission is to develop and commercialize an open-architecture, multi-analyte biosensor
platform setting new industry standards for fast, accurate and low-cost bioassay results
throughout the life sciences industry, enabling the era of precision medicine.
Our Opportunity
STI is developing disruptive new “gold-standards” in research instrumentation and medical
diagnostic equipment by integrating its proprietary micro-cavity surface plasmon resonance
(MSPR) biosensor technology in high performance substrate and cost effective reader.
The MSPR technology is enabling faster results with higher sensitivity and multiplexing
capabilities at a fraction of the price of current SPR technologies. As a result, MSPR
technology will disrupt the market for the study of molecular interaction and ultimately
transform the way diseases are diagnosed and monitored by enabling real time continuous
monitoring.
| All rights reserved. SpheroSense Technologies, 1962 South Walnut Street, Bloomington, IN 47401 Phone: 812 339 6323 |
 |  |  |  |
